Research, in Italy in 2024 Authorized 669 Clinical Trials: New Model Is Needed to Redefine Health Data Value.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.7 Articles
7 Articles
Il Tempo
Rome, 16 Sep. (Adnkronos Salute) - In 2024, in Italy, 669 clinical studies have been authorized by the Italian Medicines Agency (Aifa). Our country has a significant wealth of health data, fundamental for research, built through the National Health Service, Irccs, hospitals, universities and research centers. And the realization of the European Health Data Space (European Health Data Space), provided for by the EU Regulation 2025/327, represents…
In 2024, in Italy, 669 clinical studies have been authorized by the Italian Medicines Agency (Aifa). Our country has a significant wealth of health data, fundamental for research, built through the National Health Service, the Irccs, hospitals, universities and research centers. And the realization of the Space [...]
In 2024, in Italy, 669 clinical studies have been authorized by the Italian Medicines Agency (Aifa). Our country has a significant wealth of health data, fundamental for research, built through the National Health Service, the Irccs, hospitals, universities and research centers. And the realization of the Space [...] L'articolo Ricerca, in Italy in 2024 authorized 669 clinical studies: "It needs new model to redefine health data value" comes fro…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
